Related Experiment Video
Updated: Dec 10, 2025

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.5K
Exploring the association mechanism between metastatic osteosarcoma and non-metastatic osteosarcoma based on
1Department of Sports Medicine, Puai Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430000, P.R. China.
Summary
This study identifies key genes and regulatory factors in osteosarcoma (OS) by analyzing gene expression networks. The findings enhance understanding of molecular mechanisms driving OS progression and potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Osteosarcoma (OS) is a primary bone cancer prevalent in children and adolescents.
- Despite treatment advancements, outcomes for OS, particularly metastatic forms, remain poor.
Purpose of the Study:
- To decipher the co-expression network of common core pathogenic genes in metastatic and non-metastatic osteosarcoma.
- To identify core dysfunction modules and potential regulatory factors (transcription factors and non-coding RNAs) in osteosarcoma.
Main Methods:
- Differential gene expression analysis between metastatic and non-metastatic osteosarcoma.
- Co-expression network construction and module identification.
- Gene Ontology (GO) and KEGG pathway enrichment analysis.
- Identification of regulatory transcription factors (TFs) and non-coding RNAs (ncRNAs).
Main Results:
- Sixteen co-expression modules were identified, with ACAT1 and ATBF1 highlighted as osteosarcoma-driven genes.
- Module genes are significantly enriched in transcription factor activity, DNA binding, and ubiquitin-like protein transferase activity.
- Key pathways regulated include FcγR-mediated phagocytosis, MAPK signaling, and PI3K-Akt signaling.
- Pivot ncRNAs (e.g., CRNDE, miR-106a-5p) and TFs (e.g., NFKB1, STAT6) regulating dysfunction modules were identified.
Conclusions:
- This study elucidates a co-expression network for osteosarcoma, revealing common pathogenic genes.
- Identified core dysfunction modules and regulatory factors provide insights into molecular mechanisms.
- Findings contribute to a better understanding of the molecular associations between different osteosarcoma subtypes.
More Related Videos
Related Concept Videos
Metastasis
6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Non-Canonical Wnt Signaling Pathways
8.1K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.1K
Adaptive Mechanisms in Cancer Cells
6.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K

